-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IBP-1016 in Gastric Motility Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IBP-1016 in Gastric Motility DisorderDrug Details:IBP-1016 is under development for the treatment of gastric motility disorder...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Duchenne Muscular Dystrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Dexamethasone Sodium Phosphate in Duchenne Muscular Dystrophy Drug Details:Dexamethasone sodium phosphate is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Linrodostat Mesylate in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Linrodostat Mesylate in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: Linrodostat mesylate is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SFX-01 in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SFX-01 in Metastatic Breast CancerDrug Details:SFX-01 is under development for the treatment of human epidermal growth...
-
Company Profile
![]()
Tyson Foods Inc – Company Profile
Tyson Foods Inc (Tyson Foods) is a food processor and marketer of chicken, beef and pork. The company is involved in breeding stock, feed production, processing, marketing and transportation of chicken and related allied products. It also offers a wide range of prepared foods such as bacon, turkey, breakfast sausage, hot dogs, lunchmeat and tortillas among others. The company markets its products under Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp, and State Fair brand names. It markets...
Add to Basket -
Company Profile
![]()
Installed Building Products Inc – Company Profile
Installed Building Products Inc (IBP) is a construction and building materials company that installs insulation for home buildings. The company’s building products include rain gutters, shower doors, garage doors, closet shelving and mirrors for residential, fireplaces, window blinds, door locksets and bath hardware. Its insulation materials comprise spray foam insulation materials, fiberglass insulation materials, and cellulose insulation materials. IBP also provides the installation of insulation and sealant materials in the areas of structures including basement and crawl spaces, building envelopes,...
Add to Basket -
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – IBP-9414
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IBP-9414 Drug Details IBP-9414 is under development for the prevention of necrotising enterocolitis (NCE)...
-
Product Insights
![]()
Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Infusion Systems are used for drug infusion and pain management. The infusion systems pipeline market research report provides comprehensive information about the infusion systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key insights on major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
-
Thematic Analysis
![]()
Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research
Microbiome is the community of microorganisms such as fungi, bacteria, and viruses, and their genetic material existing in and on the human body. Although the primary site of aggregated microbes is in the gastrointestinal (GI) tract, populations of microorganisms are also found on the surface of the skin, in the upper and lower respiratory tract, and in the genitourinary tracts. Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes (probiotics), or other...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.